UKIZUK Innovation ZonesA TAIU initiative

Compare places

Two or three clusters, read side by side across sectors, research, companies, capital, infrastructure, government designations and UKIZ relevance. There is no score and no ranking: British clusters are different from one another, not better or worse than one another.

Side by side

DimensionLeeds & West YorkshireYorkshire and the HumberCambridgeEast of EnglandNorwich & the EastEast of England
Sectors

Life Sciences, Digital Technologies, Financial Technology

Supporting: Artificial Intelligence, Advanced Manufacturing, Creative Industries

Life Sciences, Semiconductors, Engineering Biology, Artificial Intelligence

Supporting: Quantum Technologies, Advanced Materials, AgriTech & FoodTech, Digital Technologies

AgriTech & FoodTech, Engineering Biology, Clean Energy

Supporting: Life Sciences, Digital Technologies

Research
  • University of Leeds
  • University of Cambridge
  • Wellcome Sanger Institute
  • MRC Laboratory of Molecular Biology
  • University of East Anglia
  • John Innes Centre
  • Quadram Institute
Companies
  • Leeds health data and digital health cluster
  • Cambridge semiconductor and processor IP cluster

Not recorded on the map.

Infrastructure

Not recorded on the map.

Health data infrastructure, teaching hospitals and university research facilities.

  • Babraham Research Campus
  • Cambridge Science Park

University and institute laboratories, genomics and biomedical campus facilities, and semiconductor design capability.

Not recorded on the map.

Plant and food research institutes, genomics facilities and offshore energy operations bases.

Capital

Financial services depth locally, but early-stage health technology capital remains limited.

Specialist deep tech and life science funds, university-linked funds, and corporate partners; strong at seed, thinner at growth stage relative to demand.

Research council and charitable funding dominate; venture capital is scarce.

Government programmes

No place-based designation recorded.

No place-based designation recorded.

  • Freeport EastFreeports
What existsNational health data organisations, medical technology, a large financial and professional services base and a research university with data and materials strength.Extreme research density for its size: life sciences and genomics, semiconductor and processor IP, engineering biology and AI, with a mature spin-out culture and specialist investors who understand long timelines.Plant, food and genomics research of international standing, offshore energy operations and maintenance, and a significant agricultural production base on the doorstep.
What's missing · UKIZ interpretationA clear route for companies to work with health data at scale, and clinical adoption pathways that move faster than pilot projects.Ownership retention. Discovery and early company formation work; the Series B onward stage frequently transfers ownership overseas. Laboratory and scale-up space, power and housing also constrain growth.Commercial translation of agri-food science, and connection between offshore energy operations and the research base inland.
What could connect · UKIZ interpretationLeeds health data capability connected to Manchester clinical research and to medical technology manufacturing, giving companies discovery, evidence and production in one region.Cambridge discovery connected to UK manufacturing and biomanufacturing capacity, and to later-stage domestic capital, so that value created here is realised here rather than acquired out of the country.Agri-food and genomics research connected to national food manufacturing and to engineering biology capacity, and offshore operations connected to the Humber and North East energy supply chain.
UKIZ relevanceHealth data at population scale is a national asset. The proposed Manchester mission and Leeds capability are complementary rather than competing.Cambridge produces intellectual property at a rate few places match, and loses ownership of too much of it at Series B. The proposed Oxford–Cambridge zone concentrates on commercialisation and retention rather than on more discovery.Food security and biotechnology intersect here more clearly than anywhere else in Britain, and connect to the proposed Oxford–Cambridge mission.
Last verified15 August 202615 August 202615 August 2026

Proposed by UKIZ · independent · not a government designation